Search - tctmd.com

Displaying 721 - 740 of 2116

Sort: Relevancy | Date

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

News Features

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Yael L. Maxwell

November 27, 2019

Swift Angiography in Cardiac Arrest Without STEMI: No 1-Year Survival Benefit

News Conference News AHA 2019

Swift Angiography in Cardiac Arrest Without STEMI: No 1-Year Survival Benefit

November 21, 2019

EVAPORATE Hints at Slowed Plaque Progression With Icosapent Ethyl

News Conference News AHA 2019

EVAPORATE Hints at Slowed Plaque Progression With Icosapent Ethyl

November 18, 2019

ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events

News Conference News AHA 2019

ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events

November 16, 2019

ISCHEMIA-CKD: Routine Invasive Approach No Help in CKD Patients With Stable CAD

News Conference News AHA 2019

ISCHEMIA-CKD: Routine Invasive Approach No Help in CKD Patients With Stable CAD

November 16, 2019

More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA

News Conference News AHA 2019

More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA

Michael O'Riordan

November 14, 2019

News Opinion Off Script AHA 2019

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

Ajay Kirtane, MD, SM

November 12, 2019

Upfront Imaging Reduces Invasive Angiography in Patients With Unclear NSTEMI Diagnosis

News Daily News

Upfront Imaging Reduces Invasive Angiography in Patients With Unclear NSTEMI Diagnosis

Michael O'Riordan

November 11, 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

November 11, 2019

CMS Confirms Substantial Cuts to Cardiac CT Reimbursement in 2020

News Daily News

CMS Confirms Substantial Cuts to Cardiac CT Reimbursement in 2020

Yael L. Maxwell

November 08, 2019

For Percutaneous LVADs, Vascular Complications Decreasing but Still Common

News Daily News

For Percutaneous LVADs, Vascular Complications Decreasing but Still Common

November 06, 2019

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

News Daily News

Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD

Michael O'Riordan

November 05, 2019

CMS Finalizes Rule Allowing Reimbursement of PCI in Ambulatory Centers

News Daily News

CMS Finalizes Rule Allowing Reimbursement of PCI in Ambulatory Centers

November 04, 2019

Deaths After Ablation of Atrial Fibrillation ‘Concerning’ in Real-World Analysis

News Daily News

Deaths After Ablation of Atrial Fibrillation ‘Concerning’ in Real-World Analysis

Michael O'Riordan

October 29, 2019

Believing SCOT-HEART: New Analysis Probes Plausible Mechanisms of Benefit

News Daily News

Believing SCOT-HEART: New Analysis Probes Plausible Mechanisms of Benefit

October 14, 2019

Sex-Specific Troponin Cutoffs Find Many More Women With Myocardial Injury

News Daily News

Sex-Specific Troponin Cutoffs Find Many More Women With Myocardial Injury

October 14, 2019

Off Script: PCI of the Future? Let’s Break Down the Border Between Physiology and Anatomy

News Opinion Off Script TCT 2019

Off Script: PCI of the Future? Let’s Break Down the Border Between Physiology and Anatomy

October 14, 2019

Any Troponin Bump in Suspected ACS—MI or Not—Signals High CV Risk: High-STEACS

News Daily News

Any Troponin Bump in Suspected ACS—MI or Not—Signals High CV Risk: High-STEACS

October 10, 2019

IVUS-XPL at 5 Years Shows Durability of Imaging Guidance in PCI

News Conference News TCT 2019

IVUS-XPL at 5 Years Shows Durability of Imaging Guidance in PCI

October 08, 2019

Intravascular Lithotripsy Shows Good Safety at 30 Days: DISRUPT CAD II

News Conference News TCT 2019

Intravascular Lithotripsy Shows Good Safety at 30 Days: DISRUPT CAD II

Yael L. Maxwell

October 08, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.